Neurofilament light chain in cerebrospinal fluid and prediction of disease activity in clinically isolated syndrome and relapsing-remitting multiple sclerosis
出版年份 2017 全文链接
标题
Neurofilament light chain in cerebrospinal fluid and prediction of disease activity in clinically isolated syndrome and relapsing-remitting multiple sclerosis
作者
关键词
-
出版物
EUROPEAN JOURNAL OF NEUROLOGY
Volume 24, Issue 5, Pages 703-712
出版商
Wiley
发表日期
2017-03-06
DOI
10.1111/ene.13274
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa
- (2016) Jens Kuhle et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Elevated CSF neurofilament proteins predict brain atrophy: A 15-year follow-up study
- (2016) Axel Petzold et al. Multiple Sclerosis Journal
- Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity
- (2016) Jens Kuhle et al. Multiple Sclerosis Journal
- Neurofilament light chain level is a weak risk factor for the development of MS
- (2016) Georgina Arrambide et al. NEUROLOGY
- Dynamic Response Genes in CD4+ T Cells Reveal a Network of Interactive Proteins that Classifies Disease Activity in Multiple Sclerosis
- (2016) Sandra Hellberg et al. Cell Reports
- Elevated CSF neurofilament proteins predict brain atrophy: A 15-year follow-up study
- (2016) Axel Petzold et al. Multiple Sclerosis Journal
- Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity
- (2016) Jens Kuhle et al. Multiple Sclerosis Journal
- Molecular biomarkers in cerebrospinal fluid of multiple sclerosis patients
- (2015) Brit Fitzner et al. AUTOIMMUNITY REVIEWS
- Biomarkers in multiple sclerosis
- (2015) William J. Housley et al. CLINICAL IMMUNOLOGY
- Cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain predict multiple sclerosis development and disability after optic neuritis
- (2015) S Modvig et al. Multiple Sclerosis Journal
- The only certain measure of the effectiveness of multiple sclerosis therapy is cerebrospinal neurofilament level—NO
- (2015) Georgina Arrambide et al. Multiple Sclerosis Journal
- The only certain measure of the effectiveness of multiple sclerosis therapy is cerebrospinal neurofilament level – YES
- (2015) Jonatan Salzer Multiple Sclerosis Journal
- Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis
- (2015) M Alba Mañé Martínez et al. Multiple Sclerosis Journal
- Chitinase 3-like proteins as diagnostic and prognostic biomarkers of multiple sclerosis
- (2015) G Hinsinger et al. Multiple Sclerosis Journal
- Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis
- (2015) J. Kuhle et al. NEUROLOGY
- Cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain predict multiple sclerosis development and disability after optic neuritis
- (2015) S Modvig et al. Multiple Sclerosis Journal
- The only certain measure of the effectiveness of multiple sclerosis therapy is cerebrospinal neurofilament level—NO
- (2015) Georgina Arrambide et al. Multiple Sclerosis Journal
- The only certain measure of the effectiveness of multiple sclerosis therapy is cerebrospinal neurofilament level – YES
- (2015) Jonatan Salzer Multiple Sclerosis Journal
- Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis
- (2015) M Alba Mañé Martínez et al. Multiple Sclerosis Journal
- Chitinase 3-like proteins as diagnostic and prognostic biomarkers of multiple sclerosis
- (2015) G Hinsinger et al. Multiple Sclerosis Journal
- Is it time to target no evident disease activity (NEDA) in multiple sclerosis?
- (2015) Gavin Giovannoni et al. Multiple Sclerosis and Related Disorders
- Levels and Age Dependency of Neurofilament Light and Glial Fibrillary Acidic Protein in Healthy Individuals and Their Relation to the Brain Parenchymal Fraction
- (2015) Mattias Vågberg et al. PLoS One
- Biomarkers of Therapeutic Response in Multiple Sclerosis: Current Status
- (2014) Violaine K. Harris et al. Molecular Diagnosis & Therapy
- Brain atrophy and lesion load predict long term disability in multiple sclerosis
- (2013) Veronica Popescu et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- A comparative study of CSF neurofilament light and heavy chain protein in MS
- (2013) Jens Kuhle et al. Multiple Sclerosis Journal
- CSF inflammation and axonal damage are increased and correlate in progressive multiple sclerosis
- (2012) Jeppe Romme Christensen et al. Multiple Sclerosis Journal
- Neurofilaments as biomarkers in multiple sclerosis
- (2012) Charlotte E Teunissen et al. Multiple Sclerosis Journal
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
- (2011) Chris H. Polman et al. ANNALS OF NEUROLOGY
- Indications of Th1 and Th17 responses in cerebrospinal fluid from patients with Lyme neuroborreliosis: a large retrospective study
- (2011) Anna J Henningsson et al. Journal of Neuroinflammation
- Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab
- (2010) Martin Gunnarsson et al. ANNALS OF NEUROLOGY
- Neurofilament light as a prognostic marker in multiple sclerosis
- (2010) Jonatan Salzer et al. Multiple Sclerosis Journal
- Osteopontin concentrations are increased in cerebrospinal fluid during attacks of multiple sclerosis
- (2010) Lars Börnsen et al. Multiple Sclerosis Journal
- Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course
- (2010) Mohsen Khademi et al. Multiple Sclerosis Journal
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started